BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21849862)

  • 1. Geographic difference in outcomes of congenital toxoplasmosis.
    Vasconcelos-Santos DV; Queiroz Andrade GM
    Pediatr Infect Dis J; 2011 Sep; 30(9):816-7; author reply 817. PubMed ID: 21849862
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance.
    Peyron F; Garweg JG; Wallon M; Descloux E; Rolland M; Barth J
    Pediatr Infect Dis J; 2011 Jul; 30(7):597-600. PubMed ID: 21278618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation.
    Bachmeyer C; Mouchnino G; Thulliez P; Blum L
    J Infect; 2006 Feb; 52(2):e55-7. PubMed ID: 16043225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Congenital toxoplasmosis].
    Lappalainen M; Koskiniemi M
    Duodecim; 1988; 104(4):239-46. PubMed ID: 3168831
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of congenital toxoplasmosis].
    Koppe JG
    Ned Tijdschr Geneeskd; 1992 Aug; 136(31):1501-4. PubMed ID: 1495566
    [No Abstract]   [Full Text] [Related]  

  • 6. Ocular manifestations in congenital toxoplasmosis.
    Kodjikian L; Wallon M; Fleury J; Denis P; Binquet C; Peyron F; Garweg JG
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):14-21. PubMed ID: 15906073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed onset of severe neonatal toxoplasmosis.
    Al-Hamod D; Vauloup C; Goulet M; Zupan-Simunek V; Castel C; Boileau P
    J Perinatol; 2010 Mar; 30(3):231-2. PubMed ID: 20182429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital toxoplasmosis: the importance of the western blot method to avoid unnecessary therapy in potentially infected newborns.
    Tridapalli E; Capretti M; Farneti G; Marangoni A; Cevenini R; Faldella G
    Acta Paediatr; 2008 Sep; 97(9):1298-300. PubMed ID: 18616630
    [No Abstract]   [Full Text] [Related]  

  • 9. Congenital toxoplasmosis.
    Olliaro P
    Clin Evid; 2004 Dec; (12):1058-61. PubMed ID: 15865702
    [No Abstract]   [Full Text] [Related]  

  • 10. [Congenital toxoplasmosis].
    Padelt H
    Z Arztl Fortbild (Jena); 1982 Sep; 76(18):828-31. PubMed ID: 6758380
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants.
    Kaye A
    J Pediatr Health Care; 2011; 25(6):355-64. PubMed ID: 22018426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
    Villena I; Quereux C; Pinon JM
    Prenat Diagn; 1998 Jul; 18(7):754-6. PubMed ID: 9706662
    [No Abstract]   [Full Text] [Related]  

  • 13. Congenital toxoplasmosis.
    Olliaro P
    Clin Evid; 2003 Jun; (9):763-6. PubMed ID: 12967389
    [No Abstract]   [Full Text] [Related]  

  • 14. [Congenital toxoplasmosis and late sequelae].
    Loewer-Sieger DH; Koppe JG; de Roever-Bonnet H
    Ned Tijdschr Geneeskd; 1985 Nov; 129(47):2253-6. PubMed ID: 4088329
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children.
    Faucher B; Garcia-Meric P; Franck J; Minodier P; Francois P; Gonnet S; L'ollivier C; Piarroux R
    J Infect; 2012 Jan; 64(1):104-9. PubMed ID: 22051915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?].
    Genuini M; Freihuber C; Girard I; de Montgolfier I; Kieffer F; Mitanchez D
    Arch Pediatr; 2011 Oct; 18(10):1084-6. PubMed ID: 21885264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postnatal therapy for congenital toxoplasmosis: a comparison of 2 different treatment approaches].
    Pohl-Schickinger A; Feiterna-Sperling C; Weizsäcker K; Bührer C
    Z Geburtshilfe Neonatol; 2012 Apr; 216(2):73-6. PubMed ID: 22517047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Congenital toxoplasmosis following infection occurring late in pregnancy].
    Ben Abdallah R; Siala E; Maatoug R; Souissi O; Aoun K; Bouratbine A
    Arch Pediatr; 2011 Jul; 18(7):758-60. PubMed ID: 21632221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxoplasmosis.
    Poindexter HA
    J Natl Med Assoc; 1973 Sep; 65(5):399-401 passim. PubMed ID: 4795539
    [No Abstract]   [Full Text] [Related]  

  • 20. Positive benefit of postnatal treatment in congenital toxoplasmosis.
    Gomez-Marin JE; delaTorre A
    Arch Dis Child; 2007 Jan; 92(1):88-9. PubMed ID: 17185453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.